About Maksim Mamonkin
Form D filings for March Biosciences in 2024 list Maksim Mamonkin as executive officer and director.
Maksim Mamonkin first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Maksim Mamonkin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Maksim Mamonkin works with at each company, as listed on that company's latest Form D.
March Biosciences, Inc. · Form D, Oct 22, 2024
TL
Thomas Luby
Director
PO
Peter Olagunju
Director
JP
Joseph Petrosino
Director
SH
Sarah Hein
Co-Founder, Chief Executive Officer and director